00:04 , Mar 9, 2019 |  BC Extra  |  Company News

Management tracks: Lundbeck hires first CBO; ICT opens U.S. office

Neurology company Lundbeck hired Keld Flintholm Jørgensen as its first CBO. Jørgensen, who will begin at H. Lundbeck A/S (CSE:LUN) April 4, is global head of strategic partnering at Roche (SWX:ROG;OTCQB:RHHBY). Innovative Cellular Therapeutics Co....
17:33 , Mar 8, 2019 |  BC Week In Review  |  Financial News

Genome editing company Precision proposes $100M IPO

With plans to bring an allogeneic CAR T immunotherapy into the clinic, Precision BioSciences Inc. (Durham, N.C.) proposed March 1 to raise up to $100 million in an IPO on NASDAQ. Precision plans to start...
22:34 , Mar 7, 2019 |  BC Extra  |  Preclinical News

Beyond cancer: CAR T cells treat lupus in mice

University of Tennessee researchers have shown that CD19-targeted CAR T cells could help treat lupus, suggesting the approach could be applied to diseases beyond cancer. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by...
00:52 , Mar 7, 2019 |  BioCentury  |  Regulation

Gottlieb’s durable reforms

While most of the changes Scott Gottlieb has set in motion in just under two years as FDA commissioner are works in progress, and some may falter in his absence, an important number are well...
00:32 , Mar 6, 2019 |  BC Extra  |  Company News

Management tracks: Gilead's Riva leaving for Glenmark innovation business

Gilead EVP of Oncology Therapeutics Alessandro Riva is leaving the company to join Glenmark's innovation business as CEO, effective April 2. Gilead said it is seeking a replacement. The news comes just days after Daniel...
00:22 , Mar 5, 2019 |  BC Extra  |  Company News

Lilly offers cheaper insulin, pressuring competitors

Lilly will offer a new, lower cost insulin that is substitutable for Humalog at pharmacies. While at least one patient group says it's not enough, the move puts pressure on the pharma’s competitors. Months of...
00:53 , Mar 2, 2019 |  BC Extra  |  Financial News

Genome editing company Precision proposes $100M IPO

With plans to bring an allogeneic CAR T immunotherapy into the clinic, Precision BioSciences Inc. (Durham, N.C.) proposed Friday to raise up to $100 million in an IPO on NASDAQ. Precision plans to start this...
20:00 , Mar 1, 2019 |  BC Week In Review  |  Financial News

Hookipa raises $37.4M series D

Hookipa Pharma Inc. (New York, N.Y.) raised $37.4 million (€33 million) on Feb. 26 in a series D round led by Redmile Group. The company is developing a pipeline of vaccines based on its VaxWave...
18:28 , Feb 26, 2019 |  BC Extra  |  Financial News

Hookipa seeking clinical progress with $37.4M series D round

Hookipa Pharma Inc. (New York, N.Y.) raised $37.4 million (€33 million) in a series D round of funding led by Redmile Group. The company is developing a pipeline of vaccines based on its VaxWave and...
02:03 , Feb 23, 2019 |  BioCentury  |  Product Development

Benchmarks for NASH

Benchmarking clinical value in NASH will require more than the topline data reported this week by Intercept Pharmaceuticals Inc. The readout gained Ocaliva obeticholic acid the title of first NASH therapy to meet in Phase...